Influenza and pneumococcal vaccination coverage rates in Uppsala County,Sweden, during the winter of 2004-2005 |
| |
| Affiliation: | 1. Chemical Biology Ventures, Abingdon, Oxfordshire, UK;2. Abgentis, Edgbaston, Birmingham, UK;3. Persica Pharmaceuticals, Canterbury, Kent, UK;4. Transcrip Partners Reading, Berkshire, UK;5. Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK;6. Novacta Biosystems, Welwyn Garden City, Hertfordshire, UK;7. Cantab Anti-infectives, Welwyn Garden City, Hertfordshire, UK;8. Phico Therapeutics, Babraham, Cambridge, UK;9. Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY, USA;10. Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK;11. Absynth Biologics, Liverpool, UK;12. School of Pharmacy, Queen''s University, Belfast, UK;13. Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada;14. Evolution Biotechnologies, Ampthill, Bedfordshire, UK;15. Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, UK;p. Institute of Infection and Immunity, St George''s, University of London, London, UK;q. TiKa Diagnostics, London, UK;r. School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK;s. Queen Victoria Hospital NHS Foundation Trust, East Grinstead, West Sussex, UK;t. Institute of Infection and Global Health, University of Liverpool, Liverpool, UK;u. Procarta Biosystems, Norwich, UK;v. Icelandic Medicines Agency, Reykjavik, Iceland;w. GlaxoSmithKline, Collegeville, Pennsylvania, PA, USA;x. MedImmune, Gaithersburg, MD, USA;y. Department of Medicine, Imperial College London, London, UK;z. Kaleido Biosciences, Cambridge, MA, USA;11. Plasgene, Edgbaston, Birmingham, UK;12. Pan-Provincial Vaccine Enterprise, Saskatoon, SK, Canada;13. Evotec, Manchester, UK;14. AstraZeneca, Boston, MA, USA;15. F2G, Manchester, UK;1. German Centre for Infection Research, Tübingen University Hospital, Tübingen, Germany;2. Verona University Hospital, Verona, Italy;3. World Health Organization Collaborating Centre on Patient Safety, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland;4. Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa;5. European Centre for Disease Prevention and Control, Stockholm, Sweden;6. EA 4360 APEMAC, Nancy University Hospital, Lorraine University, Nancy, France;7. Central Hospital, Växjö, Sweden;8. University Medical Center, Utrecht, Netherlands;9. Amphia Hospital, Breda, Netherlands;10. Laboratory for Microbiology and Infection Control, Tel Aviv University, Tel Aviv, Israel;11. Laval University and Canadian Institutes for Health Research, Québec, QC, Canada;12. Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator CARB-X, Boston University, Boston, MA, USA;13. Centers for Disease Control and Prevention, Atlanta, GA, USA;14. European Medicines Agency, London, UK;15. US Food and Drug Administration, Washington, DC, USA;p. Antibacterials Program Biomedical Advanced Research and Development Authority, Washington, DC, USA;q. Austin Health, University of Melbourne, Melbourne, VIC, Australia;r. Department of Infectious Diseases and Microbiology, University of Otago, Dunedin, New Zealand;s. Children''s National Health System, George Washington University, Washington, DC, USA;t. Center for Anti-infective Agents, Vienna, Austria;u. Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland;1. Gut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK;2. Norwich Medical School, University of East Anglia, Norwich, UK;3. Intestinal Microbiome, School of Life Sciences, ZIEL Institute for Food & Health, Technical University of Munich, Munich, Germany;1. World Health Organization, Geneva, Switzerland;2. Department of Infectious Disease, Imperial College London, London, UK;3. Global Antibiotic Research and Development Partnership, Geneva, Switzerland;4. Unité Mixte Internationale 233 IRD-U1175 INSERM, Université de Montpellier, Institut de Recherche pour le Développement, Montpellier, France;5. Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK |
| |
| Abstract: | ![]()
|
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
